Preliminary experience with lateral pelvic lymph node dissection in locally advanced XXXX .

@entity1 @entity66 @entity5 @entity190 @entity1600 @entity348 @entity3 @entity16365
BACKGROUND: In 15 % to 25  % of @entity1 , the @entity1600 ( @entity1600 ) are known to be involved especially with @entity5 lying below the peritoneal reflection. While @entity348 ( @entity348 ) ensures removal of locoregional lymph nodes, it does not address the @entity1600 . @entity1600 ( @entity1600 ) is being performed in selected scenarios for persistent @entity1600 after administration of neoadjuvant chemoradiotherapy (NACTRT). Through our study, we share our initial experience with @entity1600 in @entity1 with persistent pelvic nodes after NACTRT in advanced @entity5 . METHODS: From October 2013 to November 2014, eight @entity1 underwent @entity348 with @entity1600 after NACTRT. @entity1600 was performed when pelvic node @entity3 was suspected on preoperative magnetic resonance imaging (MRI) and persisted following preoperative NACTRT. Clinicopathological and perioperative details were recorded for these eight @entity1 . RESULTS: Out of the 144 @entity1 operated with curative intent for rectal @entity16365 , eight (5  %) @entity1 had persistent lateral pelvic nodes following NACTRT. These @entity1 underwent a @entity348 with @entity1600 . The median operative time was 240  min, and the median @entity190 was 800  mL. Two out of eight @entity1 showed @entity66 in the lateral pelvic nodes (i.e. 25  %). Of these two @entity1 , one also had @entity66 in the mesorectal nodes, post NACTRT. The median length of hospital stay was 6  days. No genitourinary complications were reported. The median follow up for these eight @entity1 was 13  months (6-16  months). The 1  year disease free survival was 100  % with all @entity1 surviving till date. CONCLUSION: @entity1600 can be performed with acceptable perioperative outcomes in carefully selected @entity1 .
